Literature DB >> 28531646

Lifetime presence of psychotic symptoms in bipolar disorder is associated with less favorable socio-demographic and certain clinical features.

Bernardo Dell'Osso1, Giulia Camuri2, Laura Cremaschi2, Cristina Dobrea2, Massimiliano Buoli2, Terence A Ketter3, A Carlo Altamura2.   

Abstract

BACKGROUND: The presence of psychotic symptoms in bipolar disorder (BD) is considered a feature of higher severity of illness and, in particular, of manic episodes in bipolar I disorder (BD I). However, the possibility to apply the "with psychotic features" specifier to major depressive episodes in either bipolar II disorder (BD II) or BD I highlights the need for additional research in this area.
METHODS: The present study assessed the lifetime presence of psychotic symptoms and related socio-demographic and clinical features in a large sample of BD patients (N=360), with (BDPs, N=207) and without a lifetime history of psychosis (BDNPs, N=153).
RESULTS: An overall less favorable socio-demographic profile was observed in BDPs vs BDNPs. In terms of clinical variables, BDPs vs BDNPs had: earlier age at onset (27.7±10.5 vs 30.1±12.3years; p=0.02), higher rates of BD I diagnosis (95.7% vs 45.8%; p<0.001), more elevated (manic/hypomanic/mixed) polarity of first (55.2% vs 24.4%; p<0.001) and most recent episode (69.8% vs 35.6%; p<0.001), more comorbid alcohol/substance use disorder (38.1% vs 21.9%; p=0.002), more lifetime hospitalizations (3.8±6.1 vs 2±3; p=0.002) and involuntary commitments (1±1.9 vs 0.1±0.4; p<0.001), more history of psychosocial rehabilitation (17.9% vs 5.7%; p=0.001), more current antipsychotic use (90.1% vs 70.9%; p<0.001), and lower GAF (62.3±14.2 vs 69.3±12.5; p<0.001), but shorter duration of most recent episode (34.1±45.4 vs 50.3±65.7days; p=0.04), lower rates of comorbid anxiety disorders (23.9% vs 38.2%; p=0.005), and antidepressant use (19.4% vs 56.6%; p<0.001).
CONCLUSIONS: The present findings indicate an overall worse profile of socio-demographic and certain clinical characteristics associated with the lifetime presence of psychotic symptoms in bipolar patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28531646     DOI: 10.1016/j.comppsych.2017.04.005

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  5 in total

1.  Gray matter bases of psychotic features in adult bipolar disorder: A systematic review and voxel-based meta-analysis of neuroimaging studies.

Authors:  Xiuli Wang; Fangfang Tian; Song Wang; Bochao Cheng; Lihua Qiu; Manxi He; Hongming Wang; Mingjun Duan; Jing Dai; Zhiyun Jia
Journal:  Hum Brain Mapp       Date:  2018-08-10       Impact factor: 5.038

2.  Bipolar Disorder and Polysubstance Use Disorder: Sociodemographic and Clinical Correlates.

Authors:  Andrea Aguglia; Antimo Natale; Laura Fusar-Poli; Andrea Amerio; Edoardo Bruno; Valeria Placenti; Eleonora Vai; Alessandra Costanza; Gianluca Serafini; Eugenio Aguglia; Mario Amore
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

3.  Prevalence and Associated Features of Anxiety Disorder Comorbidity in Bipolar Disorder: A Meta-Analysis and Meta-Regression Study.

Authors:  Hale Yapici Eser; Anil S Kacar; Can M Kilciksiz; Merve Yalçinay-Inan; Dost Ongur
Journal:  Front Psychiatry       Date:  2018-06-27       Impact factor: 4.157

4.  Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms.

Authors:  Linn Rødevand; Shahram Bahrami; Oleksandr Frei; Aihua Lin; Osman Gani; Alexey Shadrin; Olav B Smeland; Kevin S O' Connell; Torbjørn Elvsåshagen; Adriano Winterton; Daniel S Quintana; Guy F L Hindley; Maren C F Werner; Srdjan Djurovic; Anders M Dale; Trine V Lagerberg; Nils Eiel Steen; Ole A Andreassen
Journal:  Transl Psychiatry       Date:  2021-01-05       Impact factor: 6.222

5.  Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.

Authors:  Subho Chakrabarti; Navdeep Singh
Journal:  World J Psychiatry       Date:  2022-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.